The clinical efficacy and safety of levofloxacin mesylate in treatment of urinary tract infections
Abstract
Objective:To evaluate the efficacy and safety of levofloxacin mesylate in treatment of urinary tract infections.Methods:The study was conducted in 30 patients with urinary tract bacterial infections and 70 patients who are going to receive urinary tract operations.The former patients were treated with 400mg/d i.v.levofloxacin mesylate for 5～7 d to manage infections and the latter patients were treated with 400mg/d i.v.levofloxacin mesylate for 5d to prevent infections.Results:A total effective rate of 93.3% including a cure rate of 86.7% was obtained with 2 cases of mild rash(2%) and 2 cases of elevated liver function(2%).Conclusion:Levofloxacin mesylate is an effective and safe agent for treatment of urinary tract infections with mild side effect.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.